Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

Top Cited Papers
Open Access
Abstract
Universal vaccination of children 6 to 59 months of age with trivalent inactivated influenza vaccine has recently been recommended by U.S. advisory bodies. To evaluate alternative vaccine approaches, we compared the safety and efficacy of intranasally administered live attenuated influenza vaccine with those of inactivated vaccine in infants and young children.

This publication has 13 references indexed in Scilit: